Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital plus phototherapy for term neonates with non-hemolytic hyperbilirubinemia
IRCT20130812014333N231Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Nov 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of phenobarbital in neonatal hyperbilirubinemia (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Blood bilirubin level. Started Nov 2024; status: completed.
02
Drugs
phenobarbital
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20130812014333N231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N231.